Joris Schuurmans
Directeur Général chez Cergentis BV
Postes actifs de Joris Schuurmans
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Directeur des opérations | 01/06/2013 | - |
Cergentis BV
 Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | Directeur Général | 01/06/2020 | - |
Historique de carrière de Joris Schuurmans
Anciens postes connus de Joris Schuurmans
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOCARTIS GROUP NV | Directeur des opérations | - | - |
Statistiques
Internationale
| Suisse | 2 |
| Belgique | 2 |
| Pays-Bas | 2 |
Opérationnelle
| Chief Operating Officer | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOCARTIS GROUP NV | Health Technology |
| Entreprise privées | 2 |
|---|---|
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Health Technology |
Cergentis BV
Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | Commercial Services |
- Bourse
- Insiders
- Joris Schuurmans
- Expérience
